Journal of Experimental & Clinical Cancer Research · 2023 · 30 citations · 30 references
MedicineCancer BiologyOncologyApoptosisDna RepairMolecular OncologyApoptosis ResistanceColorectal CancerDna Damage SignalingDna Damage-induced ApoptosisMolecular Tumor ProfilingRadiation TherapyCancer Cell RadiosensitivityCell Cycle InhibitionColorectal Cancer RadiotherapyMolecular Prognostic MarkersPrognostic Marker AssessmentPrognostic Marker EvaluationPrognostic Tumor MarkersRadiotherapy Resistance
BACKGROUND: Neoadjuvant radiotherapy has been used as the standard treatment of colorectal cancer (CRC). However, radiotherapy resistance often results in treatment failure. To identify radioresistant genes will provide novel targets for combined treatments and prognostic markers. METHODS: Through high content screening and tissue array from CRC patients who are resistant or sensitive to radiotherapy, we identified a potent resistant gene SUMO specific peptidase 5 (SENP5). Then, the effect of SENP5 on radiosensitivity was investigated by CCK8, clone formation, comet assay, immunofluorescence and flow cytometric analysis of apoptosis and cell cycle to investigate the effect of SENP5 on radiosensitivity. SUMO-proteomic mass spectrometry combined with co-immunoprecipitation assay were used to identify the targets of SENP5. Patient-derived organoids (PDO) and xenograft (PDX) models were used to explore the possibility of clinical application. RESULTS: We identified SENP5 as a potent radioresistant gene through high content screening and CRC patients tissue array analysis. Patients with high SENP5 expression showed increased resistance to radiotherapy. In vitro and in vivo experiments demonstrated that SENP5 knockdown significantly increased radiosensitivity in CRC cells. SENP5 was further demonstrated essential for efficient DNA damage repair in homologous recombination (HR) dependent manner. Through SUMO mass spectrometry analysis, we characterized H2AZ as a deSUMOylation substrate of SENP5, and depicted the SUMOylation balance of H2AZ in HR repair and cancer resistance. By using PDO and PDX models, we found targeting SENP5 significantly increased the therapeutic efficacy of radiotherapy. CONCLUSION: Our findings revealed novel role of SENP5 in HR mediated DNA damage repair and cancer resistance, which could be applied as potent prognostic marker and intervention target for cancer radiotherapy.
30
Regulation of DNA repair pathway choice in S and G2 phases by the NHEJ inhibitor CYREN
Nausica Arnoult, Adriana Correia, Jiao Ma et al. · Nature · 2017 · 299 citations · Full text
The SUMO-Specific Protease SENP5 Is Required for Cell Division
Alessandra Di Bacco, Jian Ouyang, Hsiang‐Ying Lee et al. · Molecular and Cellular Biology · 2006 · 182 citations · Full text